Literature DB >> 21810982

Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease.

Mingliang Chu1, Peizeng Yang, Ranran Hu, Shengping Hou, Fuzhen Li, Yuanyuan Chen, Aize Kijlstra.   

Abstract

PURPOSE: Osteopontin (OPN) is a proinflammatory cytokine involved in chronic inflammatory diseases. This study aimed to analyze the role of OPN in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease.
METHODS: Serum levels of OPN in VKH patients and healthy controls were assayed by enzyme-linked immunosorbent assay (ELISA). Peripheral blood mononuclear cells (PBMCs) or CD4+ T cells were cultured with anti-CD3 and anti-CD28 antibodies in the absence or presence of recombinant OPN for the determination of cell proliferation and cytokines. Cell proliferation was detected using a cell counting kit. Levels of interferon (IFN)-γ and interleukin (IL)-17 were detected by ELISA. Four single nucleotide polymorphisms (SNPs) of OPN and four SNPs of OPN receptors were genotyped in 601 VKH patients and 605 healthy controls using a polymerase chain reaction-restriction fragment length polymorphism assay.
RESULTS: OPN serum levels were significantly higher in patients with active VKH than in patients with inactive VKH and in healthy controls. PBMCs or CD4+ T cells cultured with recombinant OPN induced a marked cell proliferation and profound secretion of IFN-γ and IL-17 from patients with active VKH. A significantly increased frequency of the OPN rs4754 TT genotype (P = 0.004, pc = 0.048) was observed in VKH patients compared with healthy controls. No association could be detected among the four selected SNPs of OPN receptors and VKH.
CONCLUSIONS: OPN may be relevant to the pathogenesis of VKH disease. The TT genotype of rs4754 may be a susceptible factor for VKH disease in a Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21810982     DOI: 10.1167/iovs.11-7539

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Genome-wide association analysis of Vogt-Koyanagi-Harada syndrome identifies two new susceptibility loci at 1p31.2 and 10q21.3.

Authors:  Shengping Hou; Liping Du; Bo Lei; Chi Pui Pang; Meifen Zhang; Wenjuan Zhuang; Minglian Zhang; Lulin Huang; Bo Gong; Meilin Wang; Qi Zhang; Ke Hu; Qingyun Zhou; Jian Qi; Chaokui Wang; Yuan Tian; Zi Ye; Liang Liang; Hongsong Yu; Hong Li; Yan Zhou; Qingfeng Cao; Yunjia Liu; Lin Bai; Dan Liao; Aize Kijlstra; Jianfeng Xu; Zhenglin Yang; Peizeng Yang
Journal:  Nat Genet       Date:  2014-08-10       Impact factor: 38.330

2.  Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis.

Authors:  Yunzhen Chen; Haichun Liu; Wenliang Wu; Yi Li; Jianmin Li
Journal:  J Exp Clin Cancer Res       Date:  2013-07-24

3.  TRAF5 and TRAF3IP2 gene polymorphisms are associated with Behçet's disease and Vogt-Koyanagi-Harada syndrome: a case-control study.

Authors:  Qin Xiang; Lu Chen; Shengping Hou; Jing Fang; Yan Zhou; Lin Bai; Yunjia Liu; Aize Kijlstra; Peizeng Yang
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

4.  CFI-rs7356506 polymorphisms associated with Vogt-Koyanagi-Harada syndrome.

Authors:  Ma-Li Dai; Xiu-Feng Huang; Qing-Feng Wang; Wei-Jun Cai; Zi-Bing Jin; Yuqin Wang
Journal:  Mol Vis       Date:  2016-01-14       Impact factor: 2.367

5.  The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosis.

Authors:  Hadas Lavi; Miri Assayag; Assaf Schwartz; Nissim Arish; Zvi G Fridlender; Neville Berkman
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

6.  LncRNA-XIST Promotes Proliferation and Migration in ox-LDL Stimulated Vascular Smooth Muscle Cells through miR-539-5p/SPP1 Axis.

Authors:  Yi Zhang; Yong Tang; Jianhua Yan
Journal:  Oxid Med Cell Longev       Date:  2022-01-04       Impact factor: 6.543

7.  TNFAIP3 gene polymorphisms in a Chinese Han population with Vogt-Koyanagi-Harada syndrome.

Authors:  Hong Li; Qing Liu; Shengping Hou; Liping Du; Qingyun Zhou; Yan Zhou; Aize Kijlstra; Peizeng Yang
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

8.  Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis.

Authors:  Yulan Liu; Hongbo Lei; Jixiang Zhang; Jun Wang; Kui Li; Weiguo Dong
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

9.  A genome-wide association study identifies risk loci to equine recurrent uveitis in German warmblood horses.

Authors:  Maike Kulbrock; Stefanie Lehner; Julia Metzger; Bernhard Ohnesorge; Ottmar Distl
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

Review 10.  Influence of molecular genetics in Vogt-Koyanagi-Harada disease.

Authors:  Joanne Yw Ng; Fiona Oj Luk; Timothy Yy Lai; Chi-Pui Pang
Journal:  J Ophthalmic Inflamm Infect       Date:  2014-07-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.